Increased levels of extracellular dopamine in neostriatum and nucleus accumbens after histamine H1 receptor blockade

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 358, Issue 4, 1998, Pages 423-429

  Dringenberg, Hans C ^b   De Souza Silva, M Angelica ^a   Schwarting, Rainer K W ^a   Huston, Joseph P ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b QUEEN S UNIVERSITY   (Canada)

Author keywords

Dopamine; H1 receptor antagonists; Histamine; Microdialysis; Neostriatum; Nucleus accumbens

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; CHLORPHENIRAMINE; DOPAMINE; HISTAMINE; HISTAMINE H1 RECEPTOR ANTAGONIST; HOMOVANILLIC ACID; MEPYRAMINE; URETHAN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; DRUG ABUSE; ELECTROCHEMICAL DETECTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MICRODIALYSIS; NEOSTRIATUM; NONHUMAN; NUCLEUS ACCUMBENS; RAT; REINFORCEMENT;

ANIMALS; CHLORPHENIRAMINE; DOPAMINE; HISTAMINE H1 ANTAGONISTS; MALE; MICRODIALYSIS; NEOSTRIATUM; NUCLEUS ACCUMBENS; PYRILAMINE; RATS; RATS, WISTAR;

EID: 0031710462     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00005274     Document Type: Article

References (47)

1. Airaksinen MS, Panula P (1988) The histaminergic system in the guinea pig central nervous system: an immunocytochemical mapping study using an antiserum against histamine. J Comp Neurol 273:163-186
2. Bealer SL (1993) Histamine releases norepinephrine in the paraventricular nucleus/anterior hypothalamus of the conscious rat. J Pharmacol Exp Ther 264:734-738
3. Boix F, Sandor P, Nogueira PJC, Huston JP, Schwarting RKW (1995) Relationship between dopamine release in nucleus accumbens and place preference induced by substance P injected into the nucleus basalis magnocellularis region. Neuroscience 64:1045-1055
4. 125I]iodobolpyramine. Neuroscience 26:553-600
5. Church WH, Justice JB Jr, Byrd LD (1987) Extracellular dopamine in rat striatum following uptake inhibition by cocaine, nomifensine and benztropine. Eur J Pharmacol 139:345-348
6. Cohn CK, Ball GG, Hirsch J (1973) Histamine: effect on self-stimulation. Science 180:757-758
7. De Souza-Silva MA, Mattern C, Häcker R, Nogueira PJC, Huston JP, Schwarting RKW (1997) Intranasal administration of the dopaminergic agonists L-DOPA, amphetamine, and cocaine increases dopamine activity in the neostriatum: a microdialysis study in the rat. J Neurochem 68:233-239
8. Di Chiara G, Imperato A (1988) Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely-moving rats. Proc Natl Acad Sci USA 85:5274-5278
9. Di Chiara G, Acquas H, Carboni E (1991) Role of niesolimbic dopamine in the motivational effects of drugs: brain dialysis and place preference studies. In: Willner P, Scheel-Krüger J (eds) The mesolimbic dopamine system: from motivation to action. Wiley, Chichester, pp 367-384
10. Dringenberg HC, De Souza-Silva MA, Rossmüller J, Huston JP, Schwarting RKW (1998) Histamine H1 receptor antagonists produce increases in extracellular acetylcholine in rat frontal cortex and hippocampus. J Neurochem 70:1750-1758
11. Fibiger HC, Phillips AG (1988) Mesocorticolimbic dopamine systems and reward. In: Kalivas PW, Nemeroff CB (eds) The mesocorticolimbic dopamine system. Ann NY Acad Sci 537:206-215
12. Fleckenstein AE, Lookingland KJ, Moore KE (1993) Activation of mesolimbic dopaminergic neurons following central administration of histamine is mediated by H1 receptors. Naunyn Schmiedebergs Arch Pharmacol 347:50-54
13. Frisch C, Hasenöhrl RU, Huston JP (1997) The histamine H1-antagonist chlorpheniramine facilitates learning in aged rats. Neurosci Lett 229:89-92
14. Garrison JC (1990) Histamine, bradykinin, 5-hydroxytryptamine, and their antagonists. In: Goodman AG, Wall TW, Nies AS, Taylor P (eds) The pharmacological basis of therapeutics. Pergamon Press, New York, pp 575-599
15. Hudson DM, Jenden DJ, Scremin OU, Sonnenschein RR (1985) Cortical acetylcholine efflux with hypercapnia and nociceptive stimulation. Brain Res 338:267-272
16. Huston JP, Hasenöhrl RU (1998) Evidence for an inhibitory role of neural histamine and of the tuberomammillary nucleus in the control of learning and reward processes. In: Prell GD (ed) Neurobiology of histamine. Humana Press, Clifton (in press)
17. Huston JP, Wagner U, Hasenöhrl RU (1997) The tuberomammillary nucleus projections in the control of learning, memory and reinforcement processes: evidence for an inhibitory role. Behav Brain Res 83:97-105
18. Inoue I, Yanai K, Kitamura D, Taniuchi I, Kobayasji T, Niimura K, Watanabe T, Watanabe T (1996) Impaired locomotor activity and exploratory behavior in mice lacking histamine H1 receptors. Proc Natl Acad Sci USA 93:13316-13320
19. Koob GF (1992) Dopamine, addiction and reward. Semin Neurosci 4:139-148
20. Kubo N, Shirakawa O, Kuno T, Tanaka C (1987) Antimuscarinic effects of antihistamines: quantitative evaluation by receptor-binding assay. Jpn J Pharmacol 43:277-282
21. Lahmeyer W, Steingold RG (1980) Pentazocine and tripelennamine: a drug abuse epidemic? Int J Addict 15:1219-1232
22. Leone P, Di Chiara G (1987) Blockade of D-1 receptors by SCH 23390 antagonizes morphine- and amphetamine-induced place preference conditioning. Eur J Pharmacol 135:251-254
23. Masukawa Y, Suzuki T, Misawa M (1993) Differential modification of the rewarding effects of methamphetamine and cocaine by opioids and antihistamines. Psychopharmacology 111:139-143
24. Onodera K (1991) Effects of antidepressants and antihistaminics on catalepsy induced by intracerebroventricular administration of histamine in mice. Methods Find Exp Clin Pharmacol 13:397-403
25. Palacios JM, Wamsley JK, Kuhar MJ (1981) The distribution of histamine H1-receptors in the rat brain: an autoradiographic study. Neuroscience 6:15-37
26. Panula P, Yong HYT, Costa E (1984) Histamine containing neurons in the rat hypothalamus. Proc Natl Acad Sci USA 81:2572-2576
27. Paxinos G, Watson C (1986) The rat brain in stereotaxic coordinates. 2nd edn. Academic Press, New York
28. Philippu A, Bald M, Kraus A, Dietl H (1984) In vivo release by histamine agonists and antagonists of endogenous catecholamines in the cat hypothalamus. Naunyn Schmiedebergs Arch Pharmacol 326:116-123
29. Privou C, Knoche A, Hasenöhrl RU, Huston JP (1998) H1 and H2 histaminergic antagonists applied to the nucleus basalis magnocellularis region modulate anxiety and reinforcement related processes. Neuropharmacology (in press)
30. Rada P, Mark GP, Pothos E, Hoebel BG (1991) Systemic morphine simultaneously decreases extracellular acetylcholine and increases dopamine in the nucleus accumbens of freely moving rats. Neuropharmacology 30:1133-1136
31. Rassnick S, Kornetsky C (1991) L-Histidine attenuates the effects of pentazocine on rewarding brain-stimulation. Life Sci 48:1729-1736
32. Schlicker E, Fink K, Detzner M, Göthert M (1993) Histamine inhibits dopamine release in the mouse striatum via presynaptic H3 receptors. J Neural Transm [GenSect] 93:1-10
33. Shishido S, Oishi R, Saeki K (1991) In vivo effects of some histamine H1-receptor antagonists on monoamine metabolism in the mouse brain. Naunyn Schmiedebergs Arch Pharmacol 343:185-189
34. Showalter CV, Moore L (1978) Abuse of pentazocine and tripelennamine. JAMA 239:1610-1612
35. Steinbusch HWM, Sauren Y, Groenewegen H, Watanabe T, Mulder AH (1986) Histaminergic projections from the premammillary and posterior hypothalamic region to the caudate-putamen complex in the rat. Brain Res 368:389-393
36. Suzuki T, Masukawa Y, Shiozaki Y, Misawa M (1991) Potentiation of pentazocine conditioned place preference by tripelennamine in rats. Psychopharmacology 105:9-12
37. Suzuki T, Takamori K, Misawa M, Onodera K (1995) Effects of the histaminergic system on the morphine-induced conditioned place preference in mice. Brain Res 675:195-202
38. Symchowicz S, Karduba CA, Veals J (1971) Inhibition of dopamine uptake into synaptosomes of rat corpus striatum by chlorpheniramine and its structural analogues. Life Sci 10:35-42
39. Tuomisto J, Tuomisto L (1980) Effects of histamine and histamine antagonists on the uptake and release of catecholamines and 5-HT in brain synaptosomes. Med Biol 58:33-37
40. Unterwald EM, Kucharsky LT, Williams JEG, Kornetsky C (1984) Tripelennamine: enhancement of brain-stimulation reward. Life Sci 34:149-153
41. Wagner U, Segura-Torres P, Weiler T, Huston JP (1993a) The tuberomammillary nucleus region as a reinforcement inhibiting substrate: facilitation of ipsilateral self-stimulation by unilateral ibotenic acid lesions. Brain Res 613:269-274
42. Wagner U, Weiler H-T, Huston JP (1993b) Amplification of rewarding hypothalamic stimulation following unilateral lesions in the region of the tuberomammillary nucleus. Neuroscience 52:927-932
43. Watanabe T, Taguchi Y, Shiosaka S, Tanaka J, Kubota H, Terano Y, Tohyama M, Wada H (1984) Distribution of the histaminergic neuron system in the central nervous system of rats: fluorescent immunohistochemical analysis with histidine decarhoxylase as a marker. Brain Res 295:13-25
44. Wauquier A, Niemegeers CJE (1981) Effects of chlorpheniramine, pyrilamine and astemizole on intracranial self-stimulation in rats. Eur J Pharmacol 72:245-248
45. Wise RA, Rompre P-P (1989) Brain dopamine and reward. Annu Rev Psychol 40:191-225
46. Wu TH, Acworth I, Maher TJ (1996) Effects of body temperature manipulations on striatal extracellular dopamine levels as determined using in vivo microdialysis. Proceedings of the International Conference on In Vivo Methods (Abstr) 7:81-82
47. Zetterström T, Sharp T, Ungerstedt U (1986) Further evaluation of the mechanism by which amphetamine reduces striatal dopamine metabolism: a brain dialysis study. Eur J Pharmacol 132:1-9